Zoledronic acid induces down-regulation of cysteine-rich, angiogenic inducer, 61 (CYR61) expression in androgen-resistant prostate cancer cells PC3

被引:0
|
作者
Santini, D.
Caraglia, M.
Vincenzi, B.
Altucci, L.
Bertieri, R.
Addeo, S. R.
Rosolowski, M.
Loeffler, M.
Budillon, A.
Baldi, A.
Tonini, G.
机构
[1] Univ Campus Biomed, Rome, Italy
[2] INT Fdn Pascale, Naples, Italy
[3] Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy
[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany
[5] Univ Naples 2, Sect Pathol, Dept Biochem & Biophys F Cedrangolo, Naples, Italy
[6] Novartis Oncol, Origgio, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:XI27 / XI27
页数:1
相关论文
共 12 条
  • [1] Zoledronic acid induces down-regulation of CYR 61 expression in androgen-resistant prostate cancer cells PC3
    Santini, Daniele
    Caraglia, Michele
    Vincenzi, Bruno
    Altucci, Lucia
    Bertieri, Raffaello
    Rosolowski, Maciej
    Loeffler, Markus
    Budillon, Alfredo
    Baldi, Alfonso
    Tonini, Giuseppe
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 56 - 57
  • [2] Matricellular Protein Cysteine-Rich Angiogenic Inducer 61 (CCN1/CYR61) Attenuates Fibrogenic Response In Trabecular Meshwork Cells
    Gupta, Ishita
    Pattabiraman, Padmanabhan P.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
    Ackar, Lucija
    Casjens, Swaantje
    Andreas, Antje
    Raiko, Irina
    Bruening, Thomas
    Geffken, Maria
    Peine, Sven
    Kollmeier, Jens
    Johnen, Georg
    Bartkowiak, Kai
    Weber, Daniel Gilbert
    Pantel, Klaus
    [J]. MOLECULAR ONCOLOGY, 2021, 15 (11) : 2877 - 2890
  • [4] Elevated Cysteine-rich protein 61 (CYR61/CCN1) mediates down-regulation of collagen expression in senescent human dermal fibroblasts.
    Quan, T.
    Qin, Z.
    He, T.
    Voorhees, J. J.
    Fisher, C. J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S33 - S33
  • [5] Zoledronic acid up-regulates NDRG1 expression in androgen-resistant prostate cancer cells PC3
    Tonini, Giuseppe
    Vincenzi, Bruno
    Caraglia, Michele
    Baldi, Alfonso
    Bertieri, Raffaello
    Loeffler, Markus
    Budillon, Alfredo
    Santini, Daniele
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 56 - 56
  • [6] Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells
    Marra, Monica
    Santini, Daniele
    Meo, Giuseppina
    Vincenzi, Bruno
    Zappavigna, Silvia
    Baldi, Alfonso
    Rosolowski, Maciej
    Tonini, Giuseppe
    Loeffler, Markus
    Lupu, Ruth
    Addeo, Santolo Rosario
    Abbruzzese, Alberto
    Budillon, Alfredo
    Caraglia, Michele
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (09) : 2004 - 2013
  • [7] CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY
    Caraglia, M.
    Marra, M.
    Meo, G.
    Zappavigna, S.
    Vincenzi, B.
    Baldi, A.
    Rosolowski, M.
    Loeffler, M.
    Tonini, G.
    Santini, D.
    Budillon, A.
    [J]. EJC SUPPLEMENTS, 2008, 6 (14): : 123 - 124
  • [8] Circular RNA hsa_circ_0103552 Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells through Upregulating Cysteine-Rich Angiogenic Inducer 61 (CYR61) Expression via Sponging MicroRNA-515-5p
    Huang, Qi
    He, Yujun
    Zhang, Xiaohua
    Guo, Lingji
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (02): : 171 - 181
  • [9] Zoledronic acid induces anti-cancer effects on prostate cancer cells through the modulation of the angiogenesis associated CYR61 and the androgen-differentiation associated NDRG-1 genes
    Tonini, G.
    Vincenzi, B.
    Marra, M.
    Baldi, A.
    Addeo, S.
    Loeffler, M.
    Rosolowski, M.
    Budillon, A.
    Caraglia, M.
    Santini, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Zoledronic acid up-regulates N-MYC downstream regulated gene 1 (NDRG1) expression in androgen-resistant prostate cancer cells PC3
    Tonini, G.
    Vincenzi, B.
    Baldi, A.
    Caraglia, M.
    Altucci, L.
    Rosolowski, M.
    Bertieri, R.
    Addeo, S. R.
    Loeffler, M.
    Budillon, A.
    Santini, D.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI30 - XI30